-First precision approach to IBD by utilizing a companion diagnostic to identify patients- -Phase 2a initiation in Crohn’s Disease on...
BRIDGEWATER, N.J., July 19, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced the...
BOSTON, July 19, 2021 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing...
Acquisition Advances Transformation Into Platform Company Focused on Cell, Gene Editing and Cytokine Therapy Company to hold Conference Call Today,...
VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:NPAU ), an emerging...
A global platform to market the Company’s portfolio across 40 countriesMELBOURNE, Australia, July 19, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies...
TORONTO and CHICAGO, July 19, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF)...
Figure 1 Resting LVOT-G Figure 2 Valsalva LVOT-G Phase 2 Clinical Trial of CK-274 Demonstrated Consistent and Clinically Meaningful Reductions...
Nith & Grand tailored to cannabis aficionados with discerning taste, and will feature craft flower and premium concentratesInitial launch features...
YONKERS, N.Y., July 19, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the...
YONKERS, N.Y., July 19, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the...
NEW HAVEN, Conn., July 19, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. ("BioXcel" or the "Company") (Nasdaq: BTAI), today announced...
Bob Ragusa leads Illumina global operations and is a key contributor to Illumina's growth and global scaling.Dante Labs integrated precision...
STRATHROY, Ontario, July 19, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co”, “we”, “us” or the “Company”)...
Pluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Directors Pluristem Appoints Prof. Varda...
Exclusive Global Development and Commercialization Rights for Recombinant Human Collagen-Based Biosynthetic CorneaClinical Stage Asset Has Potential for First Approved Biosynthetic...
CAMBRIDGE, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional...
NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and...
BOTHELL, Wash., July 19, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on...
Dr. White is an industry leader with over three decades of pharmaceutical experience in business management and strategy with a...